Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/13320
Full metadata record
DC FieldValueLanguage
dc.contributor.authorAbdelrahman, A Men
dc.contributor.authorBurrell, Louise Men
dc.contributor.authorJohnston, Colin Ien
dc.date.accessioned2015-05-16T03:08:59Z
dc.date.available2015-05-16T03:08:59Z
dc.date.issued1993-04-01en
dc.identifier.citationJournal of Hypertension. Supplement; 11(3): S23-6en
dc.identifier.govdoc8315514en
dc.identifier.otherPUBMEDen
dc.identifier.urihttp://ahro.austin.org.au/austinjspui/handle/1/13320en
dc.description.abstractINHIBITION OF RENIN-ANGIOTENSIN SYSTEM: It is now possible to effectively block the renin-angiotensin system at several steps by orally active inhibitors. Blockade of renin, the angiotensin coverting enzyme (ACE) or the angiotensin II (Ang II) type 1 (AT1) receptor leads to different hormonal changes. All three modes of blockade reduce aldosterone and all cause a reactive rise in plasma renin due to removal of angiotensin II tonic inhibition on renal renin release. ASSOCIATED CHANGES IN ANG I AND ANG II: AT1 blockade by losartan is followed by rises in plasma Ang I and Ang II; ACE inhibitors are associated with an increase in plasma Ang I but a fall in Ang II, whereas both plasma Ang I and Ang II fall with renin inhibition. DIFFERENCES IN MODE OF INHIBITION: Potential differences between the mode of blockade of the renin-angiotensin system include differences in the bioavailability of compounds, the effect of ACE on other peptide substrates, particularly bradykinin, the possibility of other actions or unknown substrates for renin and the presence of unblocked AT2 angiotensin receptors in the presence of high levels of Ang II. Whether these will result in clinically important differences remains to be determined.en
dc.language.isoenen
dc.subject.otherAngiotensin II.antagonists & inhibitorsen
dc.subject.otherAngiotensin-Converting Enzyme Inhibitors.pharmacologyen
dc.subject.otherAnimalsen
dc.subject.otherHumansen
dc.subject.otherMineralocorticoid Receptor Antagonists.pharmacologyen
dc.subject.otherRenin.antagonists & inhibitorsen
dc.subject.otherRenin-Angiotensin System.drug effectsen
dc.titleBlockade of the renin-angiotensin system at different sites: effect on renin, angiotensin and aldosterone.en
dc.typeJournal Articleen
dc.identifier.journaltitleJournal of Hypertension. Supplementen
dc.identifier.affiliationDepartment of Medicine, University of Melbourne, Austin Hospital, Heidelberg, Victoria, Australiaen
dc.description.pagesS23-6en
dc.relation.urlhttps://pubmed.ncbi.nlm.nih.gov/8315514en
dc.type.austinJournal Articleen
item.openairetypeJournal Article-
item.fulltextNo Fulltext-
item.languageiso639-1en-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.grantfulltextnone-
item.cerifentitytypePublications-
crisitem.author.deptCardiology-
crisitem.author.deptGeneral Medicine-
crisitem.author.deptMedicine (University of Melbourne)-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

2
checked on Feb 7, 2023

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.